Bioengineered Replacement Ears Look, Behave Like the Original
|
By LabMedica International staff writers Posted on 05 Mar 2013 |

Image: Larry Bonassar, Associate Professor of Mechanical Engineering, holds a fabricated ear printed with a 3D printer in his lab at Cornell University's Weill Hall (Photo courtesy of Lindsay France/Cornell University Photography).
Physicians have effectively constructed a duplicate of a living human ear that appears and acts the same as the real thing. Researchers believe their bioengineering technology will be effective in the long search by scientists and physicians to provide normal looking “new” ears to children born with congenital ear deformities.
In their study, published February 20, 2013, in the journal PLOS ONE, the researchers revealed how three-dimensional (3D) printing and new injectable gels made of living cells can be used to fashion ears that are identical to a human ear. Over a three-month period, the length of the study, these flexible ears progressively grew cartilage to replace the collagen that was used to help mold them.
“I believe this will be the novel solution reconstructive surgeons have long wished for to help children born with absence or severe deformity of the ear,” said the study’s co-lead author, Dr. Jason Spector, director of the Laboratory for Bioregenerative Medicine and Surgery (LBMS) and associate professor of surgery of plastic surgery in the department of surgery at Weill Cornell Medical College (New York, NY, USA), and an adjunct associate professor in the department of biomedical engineering at Cornell University (Ithaca, NY, USA). A bioengineered ear replacement like this would also help individuals who have lost part or all of their external ear in an accident or from cancer.”
Replacement ears are now constructed using compounds that have a Styrofoam-like consistency, or sometimes, surgeons will build ears from rib that is harvested from a young patient. “This surgical option is very challenging and painful for children, and the ears rarely look totally natural or perform well,” stated Dr. Spector, who is also a plastic and reconstructive surgeon at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. “All other attempts to ‘grow’ ears in the lab--including one 1997 study widely publicized by photos of ears implanted on the backs of mice—have failed in the long term.”
This Cornell bioengineered ear is the best to date in appearing and acting like a natural ear, the researchers reported. Moreover, the process of making the ears is fast—it takes only one week at most. “This is such a win-win for both medicine and basic science, demonstrating what we can achieve when we work together,” said the study’s other lead author, Dr. Lawrence J. Bonassar, associate professor and associate chair of the department of biomedical engineering at Cornell University.
The deformity that both Dr. Spector and Dr. Bonassar are trying to remedy is microtia, a congenital deformity in which the external ear is not fully developed. Dr. Spector and Dr. Bonassar have been collaborating on bioengineered human replacement parts since 2007, and Dr. Bonassar has also been working with other Weill Cornell physicians. For example, he and Weill Cornell’s neurologic surgeon Dr. Roger Härtl are currently testing bioengineered disc replacements using some of the same methods demonstrated in this current study. The researchers specifically work to develop replacements for human structures that are primarily made of cartilage—spine, nose, joints, trachea—because cartilage does not need to be vascularized with a blood supply in order to survive.
To make the ears, Dr. Bonassar and his colleagues first took a combination laser scan and panoramic photo of an ear from twin girls, which provided a digitized 3D image of their ears on a computer screen. That took 30 seconds, and did not involve any ionizing radiation. The researchers then converted that image into a digitized “solid” ear and used a 3D printer to build a mold of the ear. The researchers noted that the mold is similar to a box with a hole in the middle that is in the shape of the mirror image of the ear.
The scientists injected animal-derived collagen into that ear mold, and then added almost 250 million cartilage cells. The collagen acted as a scaffold upon which cartilage could grow. Collagen is the chief structural protein in the body of every mammal. Animal-based collagen is frequently used for cosmetic and plastic surgery. This high-density collagen gel, which Cornell researchers developed, looks similar to flexible Jell-O [a gelatin dessert] when the mold is removed.
“The process is fast,” Dr. Bonassar said. “It takes half a day to design the mold, a day or so to print it, 30 minutes to inject the gel and we can remove the ear 15 minutes later. We trim the ear and then let it culture for several days in a nourishing cell culture medium before it is implanted.”
During the three-month observation period, the cartilage in the ears grew to replace the collagen scaffold. “Eventually, the bioengineered ear contains only auricular cartilage, just like a real ear,” remarked Dr. Spector. Dr. Spector reported that if all future safety and effectiveness testing work out, it might be possible to try the first human implant of a Cornell bioengineered ear in as a short time as three years. “The innovation in this study is two-fold,” stated Dr. Bonassar. “The use of imaging technology to rapid and accurately make the shape of the ear implant is new, as is the high-density collagen gel for the mold.”
“These bioengineered ears are highly promising because they precisely mirror the native architecture of the human ear,” Dr. Spector concluded. “They should restore hearing and a normal appearance to children and others in need. This advance represents a very exciting collaboration between physicians and basic scientists. It is a demonstration of what we hope to do together to improve the lives of these patients with ear deformity, missing ears, and beyond.”
Related Links:
Weill Cornell Medical College
In their study, published February 20, 2013, in the journal PLOS ONE, the researchers revealed how three-dimensional (3D) printing and new injectable gels made of living cells can be used to fashion ears that are identical to a human ear. Over a three-month period, the length of the study, these flexible ears progressively grew cartilage to replace the collagen that was used to help mold them.
“I believe this will be the novel solution reconstructive surgeons have long wished for to help children born with absence or severe deformity of the ear,” said the study’s co-lead author, Dr. Jason Spector, director of the Laboratory for Bioregenerative Medicine and Surgery (LBMS) and associate professor of surgery of plastic surgery in the department of surgery at Weill Cornell Medical College (New York, NY, USA), and an adjunct associate professor in the department of biomedical engineering at Cornell University (Ithaca, NY, USA). A bioengineered ear replacement like this would also help individuals who have lost part or all of their external ear in an accident or from cancer.”
Replacement ears are now constructed using compounds that have a Styrofoam-like consistency, or sometimes, surgeons will build ears from rib that is harvested from a young patient. “This surgical option is very challenging and painful for children, and the ears rarely look totally natural or perform well,” stated Dr. Spector, who is also a plastic and reconstructive surgeon at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. “All other attempts to ‘grow’ ears in the lab--including one 1997 study widely publicized by photos of ears implanted on the backs of mice—have failed in the long term.”
This Cornell bioengineered ear is the best to date in appearing and acting like a natural ear, the researchers reported. Moreover, the process of making the ears is fast—it takes only one week at most. “This is such a win-win for both medicine and basic science, demonstrating what we can achieve when we work together,” said the study’s other lead author, Dr. Lawrence J. Bonassar, associate professor and associate chair of the department of biomedical engineering at Cornell University.
The deformity that both Dr. Spector and Dr. Bonassar are trying to remedy is microtia, a congenital deformity in which the external ear is not fully developed. Dr. Spector and Dr. Bonassar have been collaborating on bioengineered human replacement parts since 2007, and Dr. Bonassar has also been working with other Weill Cornell physicians. For example, he and Weill Cornell’s neurologic surgeon Dr. Roger Härtl are currently testing bioengineered disc replacements using some of the same methods demonstrated in this current study. The researchers specifically work to develop replacements for human structures that are primarily made of cartilage—spine, nose, joints, trachea—because cartilage does not need to be vascularized with a blood supply in order to survive.
To make the ears, Dr. Bonassar and his colleagues first took a combination laser scan and panoramic photo of an ear from twin girls, which provided a digitized 3D image of their ears on a computer screen. That took 30 seconds, and did not involve any ionizing radiation. The researchers then converted that image into a digitized “solid” ear and used a 3D printer to build a mold of the ear. The researchers noted that the mold is similar to a box with a hole in the middle that is in the shape of the mirror image of the ear.
The scientists injected animal-derived collagen into that ear mold, and then added almost 250 million cartilage cells. The collagen acted as a scaffold upon which cartilage could grow. Collagen is the chief structural protein in the body of every mammal. Animal-based collagen is frequently used for cosmetic and plastic surgery. This high-density collagen gel, which Cornell researchers developed, looks similar to flexible Jell-O [a gelatin dessert] when the mold is removed.
“The process is fast,” Dr. Bonassar said. “It takes half a day to design the mold, a day or so to print it, 30 minutes to inject the gel and we can remove the ear 15 minutes later. We trim the ear and then let it culture for several days in a nourishing cell culture medium before it is implanted.”
During the three-month observation period, the cartilage in the ears grew to replace the collagen scaffold. “Eventually, the bioengineered ear contains only auricular cartilage, just like a real ear,” remarked Dr. Spector. Dr. Spector reported that if all future safety and effectiveness testing work out, it might be possible to try the first human implant of a Cornell bioengineered ear in as a short time as three years. “The innovation in this study is two-fold,” stated Dr. Bonassar. “The use of imaging technology to rapid and accurately make the shape of the ear implant is new, as is the high-density collagen gel for the mold.”
“These bioengineered ears are highly promising because they precisely mirror the native architecture of the human ear,” Dr. Spector concluded. “They should restore hearing and a normal appearance to children and others in need. This advance represents a very exciting collaboration between physicians and basic scientists. It is a demonstration of what we hope to do together to improve the lives of these patients with ear deformity, missing ears, and beyond.”
Related Links:
Weill Cornell Medical College
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







